Gilead released the results of its own study testing Remdesivir on coronavirus patients today, which is full of conflicts of interest and is meaningless. The real study to watch is NIAID's clinical trial comparing 800 patients to placebo, and those results are not available yet.

— Eugene Gu, MD (@eugenegu) April 29, 2020